Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters
This novel microglia-specific, inducible CB<sub>2</sub> knockout model is the first to combine a floxed CB<sub>2</sub> allele with reporter genes, an essential advancement given the lack of reliable CB<sub>2</sub> antibodies. The findings demonstrate the model's specificity and effectiveness, while highlighting important considerations regarding Cre-mediated effects and recombination specificity. Furthermore, the floxed mouse can be crossed with any Cre line to study CB<sub>2</sub> expression and function in various tissues. This model provides a powerful platform for advancing understanding of CB<sub>2</sub> roles in microglia and supports future exploration of CB<sub>2</sub>-targeted therapeutic strategies.
Authors
- Kathryn J. Laloli (ORCID: https://orcid.org/0000-0003-1206-5461)
- Peggy Rentsch (ORCID: https://orcid.org/0000-0002-2108-3568)
- Bryce Vissel (ORCID: https://orcid.org/0000-0001-8860-8050)
- Sandy Stayte (ORCID: https://orcid.org/0000-0002-6518-1979)
Institutions
- UNSW Sydney (AU)
- St Vincent's Hospital Sydney (AU)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-19
- DOI
- https://doi.org/10.3389/fphar.2025.1682979
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Australian Government
- University of New South Wales